Goldman Sachs’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $75.5M | Buy |
|
|||||
|
2025
Q2 | $32.5M | Buy |
|
|||||
|
2025
Q1 | $23.2M | Buy |
|
|||||
|
2024
Q4 | $22.2M | Sell |
|
|||||
|
2024
Q3 | $40.2M | Buy |
|
|||||
|
2024
Q2 | $22.2M | Buy |
|
|||||
|
2024
Q1 | $13.1M | Buy |
|
|||||
|
2023
Q4 | $3.2M | Sell |
|
|||||
|
2023
Q3 | $3.04M | Sell |
|
|||||
|
2023
Q2 | $6.16M | Sell |
|
|||||
|
2023
Q1 | $15.6M | Sell |
|
|||||
|
2022
Q4 | $24.8M | Buy |
|
|||||
|
2022
Q3 | $10.1M | Buy |
|
|||||
|
2022
Q2 | $2.66M | Buy |
|
|||||
|
2022
Q1 | $2.25M | Buy |
|
|||||
|
2021
Q4 | $2.62M | Sell |
|
|||||
|
2021
Q3 | $8.48M | Buy |
|
|||||
|
2021
Q2 | $4.79M | Sell |
|
|||||
|
2021
Q1 | $7.96M | Buy |
|
|||||
|
2020
Q4 | $5.72M | Buy |
|
|||||
|
2020
Q3 | $2.85M | Sell |
|
|||||
|
2020
Q2 | $4.32M | Buy |
|